{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:05:05Z","timestamp":1793927105853,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2058-5","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T07:52:55Z","timestamp":1499068375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A red yeast rice-olive extract supplement reduces biomarkers of oxidative stress, OxLDL and Lp-PLA2, in subjects with metabolic syndrome: a randomised, double-blind, placebo-controlled trial"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3946-7313","authenticated-orcid":false,"given":"Nina","family":"Hermans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Van der Auwera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Breynaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Verlaet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess","family":"De Bruyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Van Gaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,3]]},"reference":[{"issue":"Suppl 7","key":"2058_CR1","first-page":"19","volume":"60","author":"L Duvnjak","year":"2009","unstructured":"Duvnjak L, Duvnjak M. The metabolic syndrome - an ongoing story. J Physiol Pharmacol. 2009;60 Suppl 7:19\u201324.","journal-title":"J Physiol Pharmacol."},{"issue":"6","key":"2058_CR2","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2337\/dc06-2481","volume":"30","author":"C Li","year":"2007","unstructured":"Li C, Ford ES. Is there a single underlying factor for the metabolic syndrome in adolescents? A confirmatory factor analysis. Diabetes Care. 2007;30(6):1556\u201361.","journal-title":"Diabetes Care"},{"issue":"1","key":"2058_CR3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/diacare.29.01.06.dc05-0862","volume":"29","author":"M Pladevall","year":"2006","unstructured":"Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J, et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care. 2006;29(1):113\u201322.","journal-title":"Diabetes Care"},{"issue":"21-22","key":"2058_CR4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.lfs.2009.02.026","volume":"84","author":"CK Roberts","year":"2009","unstructured":"Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci. 2009;84(21-22):705\u201312.","journal-title":"Life Sci"},{"issue":"6","key":"2058_CR5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1515\/CCLM.2008.166","volume":"46","author":"F Armutcu","year":"2008","unstructured":"Armutcu F, Ataymen M, Atmaca H, Gurel A. Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome. Clin Chem Lab Med. 2008;46(6):785\u201390.","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"2058_CR6","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/jn\/136.12.3022","volume":"136","author":"VO Palmieri","year":"2006","unstructured":"Palmieri VO, Grattagliano I, Portincasa P, Palasciano G. Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr. 2006;136(12):3022\u20136.","journal-title":"J Nutr"},{"issue":"11","key":"2058_CR7","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1253\/circj.70.1437","volume":"70","author":"K Fujita","year":"2006","unstructured":"Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J. 2006;70(11):1437\u201342.","journal-title":"Circ J"},{"issue":"10","key":"2058_CR8","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2004-0305","volume":"89","author":"B Hansel","year":"2004","unstructured":"Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab. 2004;89(10):4963\u201371.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2058_CR9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.atherosclerosis.2011.06.036","volume":"218","author":"JS Chae","year":"2011","unstructured":"Chae JS, Kim OY, Paik JK, Kang R, Seo WJ, Jeong TS, et al. Association of Lp-PLA2 activity and LDL size with interleukin-6, an inflammatory cytokine and oxidized LDL, a marker of oxidative stress, in women with metabolic syndrome. Atherosclerosis. 2011;218(2):499\u2013506.","journal-title":"Atherosclerosis"},{"issue":"6","key":"2058_CR10","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/ATVBAHA.107.142679","volume":"27","author":"M Persson","year":"2007","unstructured":"Persson M, Hedblad B, Nelson JJ, Berglund G. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. Arterioscler Thromb Vasc Biol. 2007;27(6):1411\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"19","key":"2058_CR11","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1001\/jama.299.19.2287","volume":"299","author":"P Holvoet","year":"2008","unstructured":"Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DRJ. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA. 2008;299(19):2287\u201393.","journal-title":"JAMA"},{"issue":"5","key":"2058_CR12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1365-2796.2002.01054.x","volume":"252","author":"V Sigurdardottir","year":"2002","unstructured":"Sigurdardottir V, Fagerberg B, Hulthe J. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Intern Med. 2002;252(5):440\u20137.","journal-title":"J Intern Med"},{"key":"2058_CR13","doi-asserted-by":"crossref","first-page":"934681","DOI":"10.1155\/2015\/934681","volume":"2015","author":"M Acevedo","year":"2015","unstructured":"Acevedo M, Varleta P, Kramer V, Valentino G, Quiroga T, Prieto C, et al. Comparison of lipoprotein-associated phospholipase A2 and high sensitive C-reactive protein as determinants of metabolic syndrome in subjects without coronary heart disease: in search of the best predictor. Int J Endocrinol. 2015;2015:934681.","journal-title":"Int J Endocrinol."},{"issue":"5","key":"2058_CR14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000360","volume":"2","author":"HD White","year":"2013","unstructured":"White HD, Simes J, Stewart RAH, Blankenberg S, Barnes EH, Marschner IC, et al. Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study. J Am Heart Assoc. 2013;2(5), e000360.","journal-title":"J Am Heart Assoc"},{"issue":"9725","key":"2058_CR15","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","volume":"375","author":"Lp-PLA2 Studies Collaboration","year":"2010","unstructured":"Lp-PLA2 Studies Collaboration. Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet. 2010;375(9725):1536\u201344.","journal-title":"Lancet"},{"issue":"1","key":"2058_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0971-5916.154512","volume":"141","author":"S Garg","year":"2015","unstructured":"Garg S, Madhu SV, Suneja S. Lipoprotein associated phospholipase A2 activity & its correlation with oxidized LDL & glycaemic status in early stages of type-2 diabetes mellitus. Indian J Med Res. 2015;141(1):107\u201314.","journal-title":"Indian J Med Res"},{"issue":"4","key":"2058_CR17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.freeradbiomed.2005.09.027","volume":"40","author":"MI Covas","year":"2006","unstructured":"Covas MI, de la Torre K, Farr\u00e9-Albaladejo M, Kaikkonen J, Fit\u00f3 M, L\u00f3pez-Sabater C, et al. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radic Biol Med. 2006;40(4):608\u201316.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"2058_CR18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7326\/0003-4819-145-5-200609050-00006","volume":"145","author":"MI Covas","year":"2006","unstructured":"Covas MI, Nyyss\u00f6nen K, Poulsen HE, Kaikkonen J, Zunft HJF, Kiesewetter H, et al. The effect of polyphenols in olive oil on heart disease risk factors. Ann Intern Med. 2006;145(5):333\u201341.","journal-title":"Ann Intern Med"},{"issue":"3","key":"2058_CR19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3945\/jn.109.112912","volume":"140","author":"K Torre-Carbot de la","year":"2010","unstructured":"de la Torre-Carbot K, Ch\u00e1vez-Serv\u00edn JL, Ja\u00faregui O, Castellote AI, Lamuela-Ravent\u00f3s RM, Nurmi T, et al. Elevated circulating LDL phenol levels in men who consumed virgin rather than refined olive oil are associated with less oxidation of plasma LDL. J Nutr. 2010;140(3):501\u20138.","journal-title":"J Nutr"},{"issue":"4","key":"2058_CR20","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2903\/j.efsa.2011.2033","volume":"9","author":"EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)","year":"2011","unstructured":"EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal blood HDL-cholesterol concentrations (ID 1639), maintenance of normal blood pressure (ID 3781), \u201canti-inflammatory properties\u201d (ID 1882), \u201ccontributes to the upper respiratory tract health\u201d (ID 3468), \u201ccan help to maintain a normal function of gastrointestinal tract\u201d (3779), and \u201ccontributes to body defences against external agents\u201d (ID 3467) pursuant to Article 13(1) of Regulation (EC) No 1924\/2006. EFSA J. 2011;9(4):2033.","journal-title":"EFSA J"},{"issue":"9","key":"2058_CR21","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/jn\/134.9.2314","volume":"134","author":"T Weinbrenner","year":"2004","unstructured":"Weinbrenner T, Fit\u00f3 M, de la Torre R, Saez GT, Rijken P, Tormos C, et al. Olive oils high in phenolic compounds modulate oxidative\/antioxidative status in men. J Nutr. 2004;134(9):2314\u201321.","journal-title":"J Nutr"},{"issue":"2","key":"2058_CR22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ajcn\/69.2.231","volume":"69","author":"D Heber","year":"1999","unstructured":"Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr. 1999;69(2):231\u20136.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2058_CR23","first-page":"313","volume":"34","author":"M Klimek","year":"2009","unstructured":"Klimek M, Wang S, Ogunkanmi A. Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia. P T. 2009;34(6):313\u201327.","journal-title":"P T"},{"issue":"6","key":"2058_CR24","volume":"9","author":"Y Li","year":"2014","unstructured":"Li Y, Jiang L, Jia Z, Xin W, Yang S, Yang Q, et al. A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia. PLoS One. 2014;9(6), e98611.","journal-title":"PLoS One"},{"issue":"5","key":"2058_CR25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/eje.1.02012","volume":"153","author":"CC Lin","year":"2005","unstructured":"Lin CC, Li TC, Lai MM. Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia. Eur J Endocrinol. 2005;153(5):679\u201386.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2058_CR26","first-page":"2304","volume":"9","author":"EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), European Food Safety Authority (EFSA)","year":"2011","unstructured":"EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), European Food Safety Authority (EFSA). Scientific opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL-cholesterol concentrations (ID 1648, 1700) pursuant to Article 13(1) of Regulation (EC) No 1924\/2006. EFSA J. 2011;9(4):2304.","journal-title":"EFSA J"},{"key":"2058_CR27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12906-015-0576-9","volume":"15","author":"V Verhoeven","year":"2015","unstructured":"Verhoeven V, Van der Auwera A, Van Gaal L, Remmen R, Apers S, Stalpaert M, et al. Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome? A double blind, placebo controlled randomized trial. BMC Complement Altern Med. 2015;15:52.","journal-title":"BMC Complement Altern Med."},{"issue":"16","key":"2058_CR28","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation"},{"issue":"1-2","key":"2058_CR29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchromb.2005.05.040","volume":"822","author":"N Hermans","year":"2005","unstructured":"Hermans N, Cos P, Vanden Berghe D, Vlietinck AJ, de Bruyne T. Method development and validation for monitoring in vivo oxidative stress: evaluation of lipid peroxidation and fat-soluble vitamin status by HPLC in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;822(1-2):33\u20139.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"12","key":"2058_CR30","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752\u201361.","journal-title":"J Clin Invest"},{"issue":"3","key":"2058_CR31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.0000058402.34138.11","volume":"23","author":"JF Keaney Jr","year":"2003","unstructured":"Keaney Jr JF, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003;23(3):434\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"2058_CR32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jnutbio.2007.06.011","volume":"19","author":"I Grattagliano","year":"2008","unstructured":"Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem. 2008;19(8):491\u2013504.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"2058_CR33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/cvr\/cvp367","volume":"85","author":"WY Wang","year":"2010","unstructured":"Wang WY, Li J, Yang D, Xu W, Zha RP, Wang YP. OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways. Cardiovasc Res. 2010;85(4):845\u201352.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2058_CR34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2013.08.013","volume":"231","author":"E Moutzouri","year":"2013","unstructured":"Moutzouri E, Liberopoulos EN, Tellis CC, Milionis HJ, Tselepis AD, Elisaf MS. Comparison of the effect of simvastatin versus simvastatin\/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia. Atherosclerosis. 2013;231(1):8\u201314.","journal-title":"Atherosclerosis"},{"key":"2058_CR35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1476-511X-10-170","volume":"10","author":"IT Silva","year":"2011","unstructured":"Silva IT, Mello APQ, Damasceno NRT. Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2): a review. Lipids Health Dis. 2011;10:170.","journal-title":"Lipids Health Dis."},{"issue":"1","key":"2058_CR36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1211\/jpp.59.1.0017","volume":"59","author":"N Hermans","year":"2007","unstructured":"Hermans N, Cos P, De Meyer GRY, Maes L, Pieters L, vanden Berghe D, et al. Study of potential oxidative stress animal models for the evaluation of antioxidant activity: status of lipid peroxidation and fat-soluble antioxidants. J Pharm Pharmacol. 2007;59(1):131\u20136.","journal-title":"J Pharm Pharmacol"},{"key":"2058_CR37","doi-asserted-by":"crossref","first-page":"7530820","DOI":"10.1155\/2016\/7530820","volume":"2016","author":"CN Black","year":"2016","unstructured":"Black CN, Bot M, Scheffer PG, Penninx BWJH. Sociodemographic and lifestyle determinants of plasma oxidative stress markers 8-OHdG and F2-isoprostanes and associations with metabolic syndrome. Oxid Med Cell Longev. 2016;2016:7530820.","journal-title":"Oxid Med Cell Longev."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2058-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T03:11:52Z","timestamp":1569640312000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2058-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,3]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2058"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2058-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,3]]},"article-number":"302"}}